Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection
Arun Sharma1,2, Gustavo Garcia3,4, Yizhou Wang5
1Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects human heart cells, causing damage and apoptosis. This study establishes a model for investigating cardiac complications of coronavirus disease 2019 (COVID-19).
Area of Science:
- Cardiology
- Virology
- Stem Cell Biology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents with respiratory symptoms but also cardiac complications like viral myocarditis.
- The direct impact of SARS-CoV-2 on human cardiomyocytes remains unclear, hindering understanding of COVID-19's cardiac effects.
Purpose of the Study:
- To investigate the mechanisms of SARS-CoV-2 infection in human cardiomyocytes using a human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) model.
- To elucidate the cellular and molecular responses of hiPSC-CMs to SARS-CoV-2 infection.
Main Methods:
- Utilized hiPSC-CMs as an in vitro model for SARS-CoV-2 infection.
- Employed microscopy to visualize viral entry and cytopathic effects.
- Conducted RNA sequencing to analyze gene expression changes in infected hiPSC-CMs.
Main Results:
- Demonstrated that SARS-CoV-2 can infect hiPSC-CMs via the ACE2 receptor.
- Observed viral replication, apoptosis, and cessation of beating in infected hiPSC-CMs within 72 hours.
- Revealed SARS-CoV-2 infection activates innate immune pathways, antiviral responses, and inhibits metabolic pathways, including suppressing ACE2 expression.
Conclusions:
- SARS-CoV-2 directly infects human cardiomyocytes in vitro, leading to cellular damage and functional impairment.
- The hiPSC-CM model provides a platform for studying COVID-19's cardiac mechanisms.
- This model can be utilized for screening potential cardiac-specific antiviral therapies for COVID-19.
Abstract:
Coronavirus disease 2019 (COVID-19) is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is defined by respiratory symptoms, but cardiac complications including viral myocarditis are also prevalent. Although ischemic and inflammatory responses caused by COVID-19 can detrimentally affect cardiac function, the direct impact of SARS-CoV-2 infection on human cardiomyocytes is not well understood. Here, we utilize human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a model to examine the mechanisms of cardiomyocyte-specific infection by SARS-CoV-2. Microscopy and RNA sequencing demonstrate that SARS-CoV-2 can enter hiPSC-CMs via ACE2. Viral replication and cytopathic effect induce hiPSC-CM apoptosis and cessation of beating after 72 h of infection. SARS-CoV-2 infection activates innate immune response and antiviral clearance gene pathways, while inhibiting metabolic pathways and suppressing ACE2 expression. These studies show that SARS-CoV-2 can infect hiPSC-CMs in vitro, establishing a model for elucidating infection mechanisms and potentially a cardiac-specific antiviral drug screening platform.
More Related Videos
05:06Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
10:30Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
